UNIVERSITY OF MARYLAND, BALTIMORE;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
发明人:
申请号：
EP10010752.3
公开号：
EP2382977B1
申请日:
2005.09.16
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The present invention is directed to therapeutic compositions targeting the NC Ca-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NC Ca-ATP channel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
